Evidence map›Paper›PMID 36555912›Full record

ArticleJournal of clinical medicine2022

Glaucoma Incidence and Progression in Diabetics: The Canary Islands Study Using the Laguna ONhE Application.

Marta Gonzalez-Hernandez, Daniel Gonzalez-Hernandez, Nisamar Betancor-Caro, Isabel Guedes-Guedes, Morten Kirk Guldager, Manuel Gonzalez de la Rosa

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marta Gonzalez-HernandezINSOFT S.L. 25 de Julio, 34, 38004 Santa Cruz de Tenerife, Spain.ORCID 0000-0003-0749-5774
Daniel Gonzalez-HernandezINSOFT S.L. 25 de Julio, 34, 38004 Santa Cruz de Tenerife, Spain.ORCID 0000-0001-7397-7160
Nisamar Betancor-CaroOphthalmology Department, Hospital Universitario de Canarias, Carretera Ofra S/N, 38320 San Cristobal de La Laguna, Spain.
Isabel Guedes-GuedesOphthalmology Department, Hospital Insular de Gran Canaria, Avenida de Canarias, S/N, 35016 Las Palmas de Gran Canaria, Spain.
Morten Kirk GuldagerRetinaLyze System A/S, Sankt Lukas Stiftelsen, Bernstorffsvej 20, 2900 Hellerup, Denmark.
Manuel Gonzalez de la RosaINSOFT S.L. 25 de Julio, 34, 38004 Santa Cruz de Tenerife, Spain.
Hospital Universitario de Canarias · ESHospital Universitario Insular de Gran Canaria · ES

Funding

European Union FEDER funds: "A way of doing Europe"; Red.es Project 2020 2020/0720/00098137
6 · The paper itself

Abstract

Background: Laguna ONhE provides a globin distribution function (GDF), in which a glaucoma discriminator based on deep learning plays an important role, and there is also an optimized globin individual pointer (GIP) for progression analysis. Methods: Signs of optic nerve glaucoma were identified in 1,124,885 fundus images from 203,115 diabetics obtained over 15 years and 117,813 control images. Results: A total of 743,696 images from 313,040 eyes of 173,661 diabetics were analysed. Some exclusions occurred due to excessive illumination, poor quality, or the absence of optic discs. Suspicion of glaucoma was reported in 6.70%, for an intended specificity of 99% (GDF < −15). More signs of glaucoma occur in diabetics as their years of disease increase, and after age 60, compared to controls. The GIP detected progression (p < 0.01) in 2.59% of cases with 4 controls and in 42.6% with 14 controls was higher in cases with lower GDF values. The GDF was corrected for the disc area and proved to be independent of it (r = 0.001925; p = 0.2814). Conclusions: The GDF index suggests a higher and increasing glaucoma probability in diabetics over time. Doubling the number of check-ups from four to eight increases the ability to detect GIP index progression by a factor of 5.

Indexed as

diabetesfundus photographsglaucomaoptic discoptic nerve headprogression

Identifiers

PMID36555912
PMCPMC9786827
OpenAlexW4311975082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.